The relationship between CYP1A2 and fatigue is indirect, primarily mediated by caffeine metabolism. CYP1A2 is the main enzyme responsible for breaking down caffeine in the liver. Individuals with a slow CYP1A2 variant (e.g., *1F/*1F) metabolize caffeine more slowly, which can prolong alertness but also lead to sleep disturbances if caffeine is consumed late in the day. Conversely, 'fast metabolizers' clear caffeine quickly and experience less sustained stimulation. However, the provided knowledge base contains no direct studies linking CYP1A2 to general fatigue outside the caffeine context. The evidence is therefore mechanistic and insufficient for clinical recommendations. A DNA test for CYP1A2 may offer insights into personal caffeine sensitivity, but it does not replace medical evaluation for persistent fatigue. Other causes such as iron deficiency, sleep disorders, or thyroid issues are far more significant.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-206fe78b7759f998582fe91c